Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-25 Sale |
2021-08-27 8:02 pm |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $33.34 | $277,827 | 264,329 (Direct) |
View |
| 2021-05-25 Sale |
2021-05-27 5:03 pm |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $34.27 | $285,537 | 272,662 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-25 Exercise |
2021-08-27 8:02 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $1.89 | 264,329 (Direct) |
View |
| 2021-08-25 Exercise |
2021-08-27 8:02 pm |
N/A 2029-08-06 |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $0 | 264,329 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:09 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
115,650 | $0 | 115,650 (Direct) |
View |
| 2021-05-25 Exercise |
2021-05-27 5:03 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $1.89 | 272,662 (Direct) |
View |
| 2021-05-25 Exercise |
2021-05-27 5:03 pm |
N/A 2029-08-06 |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $0 | 272,662 (Direct) |
View |
Ownership |
2020-09-24 7:27 pm |
N/A 2029-08-06 |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
0 | $0 | 462,559 (Direct) |
View |